{"id":"W2890487472","doi":"10.1200/jco.2017.35.15_suppl.4071","title":"Safety and clinical activity of durvalumab monotherapy in patients with hepatocellular carcinoma (HCC).","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":140,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Durvalumab; Internal medicine; Hepatocellular carcinoma; Interim analysis; Adverse effect; Gastroenterology; Sorafenib; Population; Clinical trial; Surgery; Oncology; Cancer; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006828168,0.0002748475,0.0006851155,0.0001838492,0.0001771472,0.0003797283,0.0001747858,0.0002839949,0.0008219723],"category_scores_gemma":[0.0007386632,0.0001251152,0.0002965638,0.000241173,0.0001428884,0.0002446043,0.0001138425,0.0005634067,0.0002814555],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006443909,"about_ca_system_score_gemma":0.0004039464,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004488101,"about_ca_topic_score_gemma":0.001443394,"domain_scores_codex":[0.9997208,0.000114529,0.00002644412,0.00003055921,0.0000704964,0.00003713978],"domain_scores_gemma":[0.999624,0.0001000856,0.0001337865,0.00001907357,0.00003132745,0.00009161147],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.125578,0.005700666,0.1691636,0.001047505,0.001558837,0.0009447105,0.0003119576,0.002577423,0.08208992,0.000225931,0.0061056,0.6046959],"study_design_scores_gemma":[0.03515468,0.2547071,0.6382891,0.0001727858,0.001726142,0.007697767,0.0001910275,0.008343535,0.03470067,0.0003578024,0.01859526,0.0000640185],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9910273,0.006528294,0.0002085827,0.0002319716,0.00002121297,0.00007048886,0.0003156219,0.00003396453,0.001562568],"genre_scores_gemma":[0.997933,0.0009222226,0.0001970392,0.0001206852,0.00003125194,0.00003052802,0.0004654823,0.000004494174,0.000295319],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0008219723,"threshold_uncertainty_score":0.004675388,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08252898576785439,"score_gpt":0.428880990834174,"score_spread":0.3463520050663196,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}